Article
Antifragile Control Systems: The Case of An Anti-Symmetric Network Model of the Tumor–Immune–Drug Interactions
2022-09-01
Abstract excerpt
A therapy’s outcome is determined by a tumor’s response to treatment which, in turn, depends on multiple factors such as the severity of the disease and the strength of patient’s immune response. Gold standard cancer therapies are in most cases fragile when sought to break the ties to either tumor kill ratio or patient toxicity. Lately, research has shown that cancer therapy can be at most robust...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 059ffdac-ba4b-5877-a7cd-6990e28b2219
- DOI
- 10.20944/preprints202209.0012.v1